These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2596736

  • 1. Increase of walking capacity after acute aminophylline administration in intermittent claudication.
    Picano E, Testa R, Pogliani M, Lattanzi F, Gaudio V, L'Abbate A.
    Angiology; 1989 Dec; 40(12):1035-9. PubMed ID: 2596736
    [Abstract] [Full Text] [Related]

  • 2. [Increase in tolerance to physical effort in patients with X syndrome after acute administration of aminophylline].
    Emdin M, Lattanzi F, Picano E.
    Medicina (Firenze); 1989 Dec; 9(2):173-5. PubMed ID: 2682120
    [Abstract] [Full Text] [Related]

  • 3. Exercise capacity after acute aminophylline administration in angina pectoris.
    Picano E, Pogliani M, Lattanzi F, Distante A, L'Abbate A.
    Am J Cardiol; 1989 Jan 01; 63(1):14-6. PubMed ID: 2909150
    [Abstract] [Full Text] [Related]

  • 4. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
    Fabry R, Monnet P, Schmidt J, Lusson JR, Carpentier PH, Baguet JC, Dubray C.
    Vasa; 2009 Aug 01; 38(3):213-24. PubMed ID: 19736632
    [Abstract] [Full Text] [Related]

  • 5. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
    Arosio E, De Marchi S, Zannoni M, Prior M, Lechi A.
    Mayo Clin Proc; 2002 Aug 01; 77(8):754-9. PubMed ID: 12173710
    [Abstract] [Full Text] [Related]

  • 6. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.
    Ahimastos AA, Walker PJ, Askew C, Leicht A, Pappas E, Blombery P, Reid CM, Golledge J, Kingwell BA.
    JAMA; 2013 Feb 06; 309(5):453-60. PubMed ID: 23385271
    [Abstract] [Full Text] [Related]

  • 7. Improved exercise capacity with acute aminophylline administration in patients with syndrome X.
    Emdin M, Picano E, Lattanzi F, L'Abbate A.
    J Am Coll Cardiol; 1989 Nov 15; 14(6):1450-3. PubMed ID: 2809002
    [Abstract] [Full Text] [Related]

  • 8. Beta blockade and intermittent claudication.
    Lepäntalo M.
    Acta Med Scand Suppl; 1985 Nov 15; 700():1-48. PubMed ID: 2865873
    [Abstract] [Full Text] [Related]

  • 9. Effect of L-carnitine on the reactive hyperemia in patients affected by peripheral vascular disease: a double-blind, crossover study.
    Brevetti G, Attisano T, Perna S, Rossini A, Policicchio A, Corsi M.
    Angiology; 1989 Oct 15; 40(10):857-62. PubMed ID: 2679240
    [Abstract] [Full Text] [Related]

  • 10. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM, Nielsen-Kudsk JE, Sondergaard HM, Jakobsen P, Jensen BS, Schmitz O, Nielsen TT.
    Diabet Med; 2006 Mar 15; 23(3):327-30. PubMed ID: 16492219
    [Abstract] [Full Text] [Related]

  • 11. Controlled trial of suloctidil in intermittent claudication.
    Verhaeghe R, Van Hoof A, Beyens G.
    J Cardiovasc Pharmacol; 1981 Mar 15; 3(2):279-86. PubMed ID: 6166799
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
    Clement DL, Duprez D, Van Wassenhove A, Brusselmans F.
    Int Angiol; 1989 Mar 15; 8(2):92-6. PubMed ID: 2681451
    [Abstract] [Full Text] [Related]

  • 14. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
    Rudofsky G.
    Wien Klin Wochenschr; 1988 Jul 15; 100(14):484-8. PubMed ID: 3062906
    [Abstract] [Full Text] [Related]

  • 15. Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication.
    Creager MA, Olin JW, Belch JJ, Moneta GL, Henry TD, Rajagopalan S, Annex BH, Hiatt WR.
    Circulation; 2011 Oct 18; 124(16):1765-73. PubMed ID: 21947297
    [Abstract] [Full Text] [Related]

  • 16. The effect of aminophylline infusion on the exercise capacity in patients with syndrome X.
    Yeşildağ O, Yazici M, Yilmaz O, Uçar R, Sağkan O.
    Acta Cardiol; 1999 Dec 18; 54(6):335-7. PubMed ID: 10672289
    [Abstract] [Full Text] [Related]

  • 17. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J, Kieser M, Hölscher U.
    Vasa; 1996 Dec 18; 25(3):265-74. PubMed ID: 8967154
    [Abstract] [Full Text] [Related]

  • 18. [Double-blind study of the effect of dipyridamole in patients with intermittent claudication].
    Baumgartner I, Schalch I, Bollinger A.
    Vasa; 1992 Dec 18; 21(4):387-91. PubMed ID: 1485474
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL, Gelso E.
    Drugs Exp Clin Res; 2002 Dec 18; 28(1):37-48. PubMed ID: 12073766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.